SWOG clinical trial number
SWOG-9216 (INT-0131) (NCIC-CTG-BR.8)

A Randomized Phase III Study of CODE Plus Thoracic Irradiation Versus Alternating CAV and EP for Extensive Stage Small Cell Lung Cancer, (NCIC CTG)

Closed
Phase
Published
Abbreviated Title
A Randomized Phase III Study of CODE Plus Thoracic Irradiation Versus Alternating CAV and EP for Extensive Stage Small Cell Lung Cancer, (NCIC CTG)
Activated
12/15/1992
Closed
04/26/1996

Research committees

Lung Cancer

Other Clinical Trials

S2414
SWOG Clinical Trial Number

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)

Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
1% Accrual
Accrual
1%
Open
Phase
A082002
SWOG Clinical Trial Number

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer

Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
CTSU/NRG-LU007
SWOG Clinical Trial Number

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial

Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open